Stoic Venture Capital

Stoic Venture Capital is an Australian venture capital firm headquartered in Sydney, established in 2020 by co-founders Guy Hedley and Dr Geoff Waring. The firm operates with a distinct focus on commercialising university research and fostering deep technology innovation within Australia. Licensed under ASIC and the 2019 VC Act, Stoic VC partners with leading Australian research institutions, including Australia's first University Fund (Uniseed), to identify and support early-stage science and engineering ventures. Their investment strategy is rooted in transforming groundbreaking academic research into commercially viable, catalytic technologies that have the potential to reshape industries and address global challenges.

Stoic Venture Capital serves scientists, engineers, and founders who are at the frontier of research, guiding them through the critical stages of development from pre-seed to Series A. The firm's multidisciplinary team, which includes partners like Harikesh Pushpapathan, brings decades of experience in building, scaling, and fundraising, complemented by a deep network designed to support portfolio companies. This hands-on approach provides crucial commercialisation support and patient capital, differentiating Stoic VC in the Australian deep tech landscape. Their commitment extends to solving complex problems across human health, advanced computing, and the physical world.

Since its inception, Stoic Venture Capital has rapidly grown its portfolio, demonstrating a significant commitment to the deep tech and life sciences sectors. The firm has made approximately 29 investments, with 20 of these publicly disclosed, and boasts 19 active companies alongside recent breakthrough exits. Noteworthy portfolio companies include Kinoxis, which is developing next-generation therapeutics; Neurode, focusing on personalised brain stimulation; BioScout, a leader in preventing airborne agricultural diseases; and Ena Respiratory, known for its universal nasal spray for viral respiratory infections. This strategic concentration on high-impact scientific and engineering advancements reflects their mission to build a robust deep technology ecosystem in Australia and establish the country as a leader in global innovation.